Abstract
On the basis of three seriously flawed sub-Saharan African randomized clinical trials into female-to-male (FTM) sexual transmission of HIV, in 2007 WHO/UNAIDS recommended circumcision (MC) of millions of African men as an HIV preventive measure, despite the trials being compromised by irrational motivated reasoning, inadequate equipoise, selection bias, inadequate blinding, problematic randomization, trials stopped early with exaggerated treatment effects, and failure to investigate non-sexual transmission. Several questions remain unanswered. Why were the trials carried out in countries where more intact men were HIV+ than in those where more circumcised men were HIV+? Why were men sampled from specific ethnic subgroups? Why were so many men lost to follow-up? Why did men in the intervention group receive additional counselling on safe sex practices? The absolute reduction in HIV transmission associated with MC was only 1.3 % (without even adjusting for known sources of error bias). Relative reduction was reported as 60 %, but after correction for lead-time bias alone averaged 49 %. In a related Ugandan RCT into male-to-female (MTF) transmission, there was a 61 % relative increase (6 % absolute increase) in HIV infection among female partners of circumcised men, some of whom were not informed that their male partners were HIV+ (also some of the men were not informed by the researchers that they were HIV+). It appears that the number of circumcisions needed to infect a woman (Number Needed to Harm) was 16.7, with one woman becoming infected for every 17 circumcisions performed. As the trial was stopped early for “futility,” the increase in HIV infections was not statistically significant, although clinically significant. In the Kenyan trial, MC was associated with at least four new incident infections. Since MC diverts resources from known preventive measures and increases risk-taking behaviors, any long-term benefit in reducing HIV transmission remains dubious.
This article was first published by Thomson Reuters in the Journal of Law and Medicine and should be cited as Boyle GJ, Hill G. Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns. (2011) 19 JLM 316. For all subscription inquiries please phone, from Australia: 1300 304 195, from Overseas: +61 2 8587 7980 or online at www.thomsonreuters.com.au/catalogue. The official PDF version of this article can also be purchased separately from Thomson Reuters.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
HIV virus neutralised with new antibodies http://news.ninemsn.com.au/article.aspx?id=7926291.
- 2.
The “ABCs” of HIV prevention 2002.
- 3.
HIV and AIDS can be stopped, World Vision Australia. http://www.worldvision.com.au/wvconnect/content.asp?topicID=19.
References
Ajwang J (2007) Uganda: HIV—circumcision isn’t enough, Monitor (Kampala), 10 April. http://allafrica.com/stories/200704091186.html
Altman D (1994) The scandal of poor medical research. BMJ 308:383–384
Auvert B, Taljaard D, Lagarde E et al (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2(11):e2
Bailey RC, Moses S, Parker CB et al (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369(9562):643–656
Bailey RC et al. (2010) The protective effect of adult male circumcision against HIV acquisition is sustained for at least 54 months: results from the Kisumu, Kenya trial. IAC, Abstract FRLBC101
Bassler D, Briel M, Montori VM et al (2010) Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 303(12):1180–1187
Bensley GA, Boyle GJ (2001) Physical, sexual, and psychological impact of male infant circumcision: an exploratory study. In: Denniston GC et al. (eds) Understanding circumcision: a multi-disciplinary approach to a multi-dimensional problem Kluwer/Plenum, NY
Bensley GA, Boyle GJ (2003) Effects of male circumcision on female arousal and orgasm. New Zealand Med J 116:595–596
Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342(25):1878–1886
Bernstein HB, Kinter AL, Jackson R et al (2004) Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. AIDS Res Hum Retroviruses 20(11):1189–1195
Beyrer C, Trapence G, Motimedi F et al (2009) Bisexual concurrency, bisexual partnerships, and HIV among Southern African men who have sex with men (MSM). Sex Transm Infect 86(4):323–327
Boyle GJ (2003) Issues associated with the introduction of circumcision into a non-circumcising society. Sex Transm Infect 79:427–428
Boyle GJ (2004) Male circumcision and risk of HIV-1 infection. Lancet 363:1997
Boyle GJ, Hill G (2011) “The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV”…and now the case against. Med J Aust 194(2):99
Boyle GJ, Svoboda JS, Price CP et al (2000) Circumcision of healthy boys: criminal assault? J Law Med 7:301–310
Boyle GJ, Goldman R, Svoboda JS et al (2002) Male circumcision: pain, trauma and psychosexual sequelae. J Health Psychol 7:329–343
Brazil says no to circumcision (2007) VivirLatino, 3 April 2007. (Retrieved Dec. 26, 2010). URL. http://www.circumcisionandhiv.com/2007/04/brazil_rejects_.html
Brewer D, Potterat JJ, Robert JM et al (2007) Male and female circumcision associated with prevalent HIV infection in virgins and adolescents in Kenya, Lesotho, and Tanzania. Ann Epidemiol 17:217–226
Brody S, Potteratt JJ (2003) Assessing the role of anal intercourse in the epidemiology of AIDS in Africa. Int J STD AIDS 14:431–436
Chao A, Bulterys M, Musanganire F et al (1994) Risk factors associated with prevalent HIV-1 infection among pregnant women in Rwanda. National university of Rwanda-Johns Hopkins university AIDS research team. Int J Epidemiol 23(2):371–380
Clouser CL, Patterson SE, Mansky LM (2010) Exploiting drug repositioning for discovery of a novel HIV combination therapy. J Virol 84(18):9301–9309
Cocks T (2006) Ugandan president rejects circumcision study, Independent Online, 22 Dec, 2006. URL. http://www.iol.co.za/index.php?set_id=1&click_id=3016&art_id=qw1166790421634B225 (Retrieved Dec. 26, 2010)
Cold CJ, Taylor JR (1999) The prepuce. BJU Int 83(Suppl. 1):34–44
Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342(25):1887–1892
Dowsett GW, Couch M (2007) Male circumcision and HIV prevention: is there really enough of the right kind of evidence? Reprod Health Matters 15(29):33–44
de Witte L, Nabatov A, Pion M et al (2007) Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 13:361–371
Dekkers W (2009) Routine (non-religious) neonatal circumcision and bodily integrity: a transatlantic dialogue. Kennedy Inst Ethics J 19(2):125–146
Dekkers M, von Elm E, Algra A et al (2010) How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol 39:89–94
Edwards SJL, Lilford RJ, Hewison J (1998) The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. Br Med J 317(7167):1209–1212
Fleming DT, Wasserheit JN (1999) From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75(1):3–17
Freedman B (1987) Equipoise and the ethics of clinical research. N Eng J Med 317(3):141–145
Fox M, Thomson M (2010) HIV/AIDS and circumcision: lost in translation. J Med Ethics 36:798–801
Garenne M (2006) Male circumcision and HIV control in Africa. PLoS Med 3(1):31
Garenne M (2008) Long-term population effect of male circumcision in generalised HIV epidemics in sub-Saharan Africa. Afr J AIDS Res 7(1):1–8
Giannetti M (2000) Circumcision and the American academy of pediatrics: should scientific misconduct result in trade association liability? Iowa Law Rev 85:1507–1568
Gifford F (1995) Community-equipoise and the ethics of randomized clinical trials. Bioethics 9(2):127–148
Gisselquist D (2007) Points to consider: responses to HIV/AIDS in Africa, Asia, and the Caribbean. Adonis & Abbey, London
Gisselquist D (2008) Denialism undermines AIDS prevention in sub-Saharan Africa. Int J STD AIDS 19:649–654
Gisselquist D (2009a) HIV infections as unanticipated problems during medical research in Africa. Accountability Res 16:199–217
Gisselquist D (2009b) Double standards in research ethics, health-care safety, and scientific rigour allowed Africa’s HIV/AIDS epidemic disasters. Int J STD AIDS 20(12):839–845
Gisselquist D, Rothenberg R, Potterat J et al (2002) HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int J STD AIDS 13:657–666
Gisselquist D, Potterat JJ, Brody S (2004) Running on empty: sexual co-factors are insufficient to fuel Africa’s turbocharged HIV epidemic. Int J STD AIDS 15:442–452
Goldman R (2004) Circumcision policy: a psychosocial perspective. Paediatr Child Health 9(9):630–633
Gray RH, Kigozi G, Serwadda D et al (2007) Male circumcision for HIV prevention in men in Rakai Uganda: a randomised trial. Lancet 369(9562):657–666
Green LW, McAllister RG, Peterson KW et al (2008) Male circumcision is not the HIV ‘vaccine’ we have been waiting for! Fut HIV Ther 2(3):293–299
Green LW, Travis JW, McAllister RG et al (2010) Male circumcision and HIV prevention: insufficient evidence and neglected external validity. Am J Prev Med 39(5):479–482
Johnson M (2010) Male genital mutilation: beyond the tolerable? Ethnicities 10(2):181–207
Karlberg JPE (2010) Personal communication (email). University of Hong Kong.
Karlberg JPE, Speers MA (2010) Reviewing clinical trials: a guide for the ethics committee. Karlberg JPE, Hong Kong
Kalichman S, Eaton L, Pinkerton S (2007) Circumcision for HIV prevention: failure to fully account for behavioral risk compensation. PloS Med 4(3):e138
Karim QA, Karim SA, Frohlich JA et al (2010) Effectiveness and safety of Tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329(5996):1168–1174
Kim DS, Lee JY and Pang MG (1999) Male circumcision: A South Korean perspective. Brit J Urol Int 83:28
Kunda Z (1990) The case for motivated reasoning. Psych Bull 108(3):480–498
Laumann EO, Masi CM, Zuckerman EW (1997) Circumcision in the United States: prevalence, prophylactic effects, and sexual practice. JAMA 277:1052–1057
Lie RK, Miller FG (2011) What counts as reliable evidence for public health policy: the case of circumcision for preventing HIV infection. BMC Med Res Methodol 11:34
Magoha GA (1999) Circumcision in various Nigerian and Kenyan hospitals. East Afr Med J 76: 583
Mattson CL, Muga R, Poulussen R, Onyango T, Bailey RC (2004) Feasibility of medical male circumcision in Nyanza province. Kenya. East Afr Med J 81:320–335
McAllister RG, Travis JW, Bollinger D et al (2008) The cost to circumcise Africa. Int J Men’s Health 7(3):307–316
Mehta SD, Gray RH, Auvert B et al (2009) Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS 23(12):1557–1564
Mills E, Siegfried N (2006) Cautious optimism for new HIV/AIDS prevention strategies. Lancet 368:1236
Millet GA, Ding H, Lauby J et al (2007) Circumcision status and HIV infection among black and Latino men who have sex with men in three US cities. J Acquir Immune Defic Syndr 46(5):643–650
Millet GA, Flores SA, Marks G et al (2008) Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 300(14):1674–1684
Moher D, Hopewell S, Schulz KF et al (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Br Med J 340:c869
Mor Z, Kent CK, Kohn RP et al (2007) Declining rates in male circumcision amidst increasing evidence of its public health benefit. PLoS ONE 2(9):e861
Montori VM, Devereaux PJ, Adhikari NK et al (2005) Randomized trials stopped early for benefit: a systematic review. JAMA 294:2203–2209
Muula AS, Prozesky HW, Mataya RH et al (2007) Prevalence of complications of male circumcision in Anglophone Africa: a systematic review. BMC Urol 7:4
Padian NS, McCoy SI, Balkus JE et al (2010) Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 24(5):621–635
Pinkerton SD (2001) Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations. Risk Anal 21:727–736
Pocock S, White I (1999) Trials stopped early: too good to be true? Lancet 353:943–944
Price C (1997) Male circumcision: an ethical and legal affront. Bull Med Ethics 128:13–19
Quinn TC, Wawer MJ, Sewankambo N et al (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. N Engl J Med 342(13):921–929
Raffle AE, Morgan K (1998) Financial inducements are equivalent to coercion. BMJ 316(7128):394
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S et al (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361(23):2209–2220
Roehr B (2010) How homophobia is fuelling Africa’s HIV epidemic. BMJ 340:c2245
Rothwell PM (2005) External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 365:82–93
Sanson-Fisher RW, Bonevski B, Green LW et al (2007) Limitations of the randomized controlled trial in evaluating population-based health interventions. Am J Prev Med 33(2):155–161
Schulz KF, Chalmers I, Hayes RJ et al (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408–412
Siegfried N, Muller M, Volmink J et al. (2003) Male circumcision for prevention of heterosexual acquisition of HIV in men (Cochrane Review). In: The Cochrane Library, Issue 3, Update Software, Oxford
Siegfried N, Muller M, Deeks et al (2005) HIV and male circumcision-A systematic review with assessment of the quality of studies. Lancet Infect Dis 5:165
Siegfried N, Muller M, Deeks JJ et al. (2009) Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2 (CD003362). URL: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD003362/frame.html
Sorrells ML, Reiss JL, Snyder MD et al (2007) Fine-touch pressure thresholds in the adult penis. BJU Int 99:864–869
Stallings RY, Karugendo E (2005) Female circumcision and HIV infection in Tanzania: for better or for worse? 3rd IAS conference HIV pathogen and treatment, Rio de Janeiro, Brazil, 24–27 July
Statement on Kenyan and Ugandan trial findings regarding male circumcision and HIV (2006) WHO, Geneva, Switzerland, December 13. http://www.who.int/mediacentre/news/statements/2006/s18/en/index.html (Retrieved Oct. 15, 2010)
Sussman JB, Hayward RA (2010) An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ 340:c2073
Taylor JR, Lockwood AP, Taylor AJ (1996) The prepuce: specialized mucosa of the penis and its loss to circumcision. Br J Urol 77:291–295
The “ABCs” of HIV prevention: report of a USAID technical meeting on behavior change approaches to primary prevention of HIV/AIDS (2002) 17 Sept
Thomas AG, Bakhireva LN, Brodine SK et al. (2004) Prevalence of male circumcision and its association with HIV and sexually transmitted infections in a U.S. navy population. Abstract no. TuPeC4861. Presented at the XV international AIDS conference, Bangkok, Thailand, 11–16 July 2004
Todd C (2001) Research participation and financial inducements. Amer J Bioethics 1(2):60–61
Urassa M, Todd J, Boerra JT et al (1997) Male circumcision and susceptibility to HIV infection among men in Tanzania. AIDS 11:73–80
Vandenbroucke JP (2008) Observational research, randomised trials, and two views of medical science. PLoS Med 5(3):e67
Van Howe RS (2010) Analysis of the circumcision/HIV randomised clinical trials. Unpublished manuscript
Van Howe RS, Storms MR (2011) How the circumcision solution in Africa will increase HIV infections. J Pub Health Africa 2:e4. doi:10.4081/jphia.2011.e4
Van Spall HG, Toren A, Kiss A et al (2007) Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297(11):1233–1240
Vines J (2006) Major potential confounder not addressed. PLoS Med 3(1):e63
Verástegui EL (2006) Consenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico. BMC Med Ethics 7:13
Wakabi W (2007) Homophobia is fuelling the AIDS epidemic in Africa. CMAJ 177(9):1017
Wassenaar D (2007) Double standards in research ethics. Case-studies: informed consent and vaccine to treat rotavirus. EU forum on ethics, research and globalisation. Brussels
Wawer MJ, Makumbi F, Kigozi G et al (2009) Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 374:229–237
Weinstein RS, Weinstein MM, Alibek K et al (2010) Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with vaccinia virus. BMC Immunol 11:23
Weller SC, Davis-Beaty K (2002) Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev Issue 1 Art. No. CD003255
Young H (2010) False assumptions. BMC Public Health 10:209. URL: http://www.circumstitions.com/HIV.html (Retrieved Dec. 23, 2010)
Zulu K, Bulawo ND, Zulu W (2006) Circumcision razor a preventative tool or a strategic vector in the transmission of HIV? A case of Zambia. Poster presented at XVI international AIDS conference, Toronto, Canada, 13–18 August 2006
Acknowledgments
The author acknowledge the assistance of George Hill, Vice-President for Bioethics and Medical Science, Doctors Opposing Circumcision, Seattle, Washington 98107, USA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
The following studies either show no relationship with circumcision status or a higher risk in circumcised men.
No relationship between HIV infection and circumcision status (13 studies)
-
1.
Hira SK, Kamanga J < Mcuacua R, et al. Genital ulcers and male circumcision as risk factors for acquiring HIV-1 in Zambia. J Infect Dis 1990; 161:584–5.
-
2.
Pépin J, Quigley M, Todd J, et al. Association between HIV-2 Infection and genital ulcer diseases among male sexually transmitted disease patients in The Gambia. AIDS 1992; 6:489–93.
-
3.
Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997; 278:2085–9.
-
4.
Chiasson M, Stoneburner RL, Hildebrandt DS, et al. Heterosexual transmission of HIV-1 associated with use of smokable freebase cocaine (crack). AIDS 1991; 5:1121.
-
5.
Carael M, Van De Perre, PH, Lepage PH, et al. Human immunodeficiency virus transmission among heterosexual couples in Africa. AIDS 1988; 2:201–5.
-
6.
Moss GB, Clemerson D, D’Costa L, et al. Association of cervical ectopy with heterosexual transmission of human immunodeficency virus: results of a study of couples in Nairobi, Kenya. J Infect Dis 1991; 164:588–91.
-
7.
Allen S, Lindan C, Serufilira A, et al. Human immunodeficiency virus infection in urban Rwanda: demographic and behavioral correlate in a representative sample of childbearing women. JAMA 1991; 266:1657–63
-
8.
Seidlin M, Vogler M, Lee E, et al. Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS 1993; 7:1247–54.
-
9.
Konde-Lule JK. Bergley SF, Downing R. Knowledge attitudes and practices concerning AIDS in Ugandans. AIDS 1989; 3:513–18.
-
10.
Van de Perre P, Clumeck N, Steens M, et al. Seroepidemiological study on sexully transmitted diseases and hepatitis B in African promiscuous heterosexuals in relation to HTLV-III infection. Eur J Epidemiol 1987; 3:14–8.
-
11.
Quigley M, Munguti K, Grosskurth H, et al. Sexual behavior patterns and other risk factors for HIV infection in rural Tanzania: a case control study. AIDS 1997; 11:237–48.
-
12.
Hudson CP, Hennis AJM, Kataaha P, et al. Risk factors for the spead of AIDS in rural Africa, hepatitis B and syphilis in southwestern Uganda. AIDS 1988; 2:255–60.
-
13.
Laumann EO, Masi CM, Zuckerman EW. Circumcision in the United States: prevalence, prophylactic effects, and sexual practice. JAMA 1997; 277:1052–7
A higher risk of HIV infection in circumcised men (4 studies)
-
1.
Barongo LR, Borgdorff W, Mosha FF, et al. The epidemiology of HIV-1 infection in rural areas, roadside settlements and rural villages in Mwanza Region, Tanzania. AIDS 1992; 6:1521–8.
-
2.
Grosskurth H, Mosha F, Todd J, et al. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. AIDS 1995; 9:927–34.
-
3.
Chao A, Bulterys M, Musanganire F, et al. Risk factors associated with prevalent HIV-1 infection among pregnant women in Rwanda. National University of Rwanda-Johns Hopkins University AIDS Research Team. Int J Epidemiol 1994; 23:371–380.
-
4.
Urassa M, Todd J, Boerra JT, et al. Male circumcision and susceptibility to HIV infection among men in Tanzania. AIDS 1997; 11:73–80 [study 1].
The orange part of each of the three right-hand bars (below the dotted lines) represents the much-hyped “60 % protection” conferred by circumcision. If just those men, whose HIV status is unknown, proved in fact to be HIV+ (red), circumcision would certainly have no protective effect whatever, but it would not take all of them to reduce the effect below statistical significance.
All three trials had significant numbers “lost from study”, their HIV status unknown (yellow + orange bars in the graphs below)—100 circumcised men (6.5 %) in South Africa, 87 (10 %) in Kenya, and 140 (3.5 %) in Uganda. (The figures are presented confusingly in the published reports because the men did not all enter the trials together, but each trial was stopped at a stroke).
Those figures are high enough in themselves to cast doubt on the validity of the results, but circumcised men who found they had HIV would be disillusioned with the trials and less likely to return. It would take only 25, 25, and 23 such men respectively to completely nullify the trials, and fewer to render the results non-significant.
From www.circumcstitions.com (retrieved 4 July 2011; reproduced with permission from the author Hugh Young, email: hugh@buzz.net.nz).
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Boyle, G.J. (2013). Critique of African RCTs into Male Circumcision and HIV Sexual Transmission. In: Denniston, G., Hodges, F., Milos, M. (eds) Genital Cutting: Protecting Children from Medical, Cultural, and Religious Infringements. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6407-1_15
Download citation
DOI: https://doi.org/10.1007/978-94-007-6407-1_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6406-4
Online ISBN: 978-94-007-6407-1
eBook Packages: MedicineMedicine (R0)